- Home
- TLPH vs PPBT Comparison
TLPH vs PPBT Comparison
Compare TLPH & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- PPBT
- Stock Information
- Founded
- TLPH 2005
- PPBT 2010
- Country
- TLPH United States
- PPBT Israel
- Employees
- TLPH N/A
- PPBT N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- TLPH Health Care
- PPBT Health Care
- Exchange
- TLPH Nasdaq
- PPBT Nasdaq
- Market Cap
- TLPH 12.7M
- PPBT 6.7M
- IPO Year
- TLPH 2011
- PPBT N/A
- Fundamental
- Price
- TLPH $0.64
- PPBT $3.42
- Analyst Decision
- TLPH Strong Buy
- PPBT Strong Buy
- Analyst Count
- TLPH 2
- PPBT 2
- Target Price
- TLPH $4.50
- PPBT $126.50
- AVG Volume (30 Days)
- TLPH 96.2K
- PPBT 2.7M
- Earning Date
- TLPH 11-13-2024
- PPBT 11-15-2024
- Dividend Yield
- TLPH N/A
- PPBT N/A
- EPS Growth
- TLPH N/A
- PPBT N/A
- EPS
- TLPH N/A
- PPBT N/A
- Revenue
- TLPH $281,000.00
- PPBT N/A
- Revenue This Year
- TLPH N/A
- PPBT N/A
- Revenue Next Year
- TLPH N/A
- PPBT N/A
- P/E Ratio
- TLPH N/A
- PPBT N/A
- Revenue Growth
- TLPH N/A
- PPBT N/A
- 52 Week Low
- TLPH $0.60
- PPBT $2.00
- 52 Week High
- TLPH $1.61
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- TLPH 39.75
- PPBT 46.33
- Support Level
- TLPH $0.60
- PPBT $3.56
- Resistance Level
- TLPH $0.76
- PPBT $4.22
- Average True Range (ATR)
- TLPH 0.07
- PPBT 0.75
- MACD
- TLPH -0.00
- PPBT -0.11
- Stochastic Oscillator
- TLPH 17.65
- PPBT 3.14
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.